S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AEON AEON Biopharma Inc

0.5785

0.0287 (5.22%)

04 Jan 2025 - Closed

Delayed by 15 minutes

Form ARS/A - Annual Report to Security Holders: [Amend]

AEON Biopharma (AMEX:AEON)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more AEON Biopharma Charts.

AEON Biopharma (AMEX:AEON)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more AEON Biopharma Charts.

AEON Biopharma Inc News

Form 8-K - Current report
Saturday 21 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 8 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (4 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 22 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 22 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 13 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Tuesday 13 August 2024 (5 months ago) • Edgar (US Regulatory)

More AEON Biopharma Inc News Articles

JP Morgan Chase

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions